Pharma Giant GlaxoSmithKline to Forgo Patents in Developing Countries

medicine.jpg

Sciencealert has reported that GlaxoSmithKline says it will no longer file patents for its medicines in the world’s 50 Least Developed Countries (LDCs) and Low Income Countries (LICs), which means that when it brings out a new HIV or cancer drug in places like Afghanistan, Rwanda, or Cambodia, it won’t prevent other manufacturers from supplying generic, more affordable versions of the same medication to help make medicine more accessible to the world’s poorest people.

Read the full story HERE

One thought on “Pharma Giant GlaxoSmithKline to Forgo Patents in Developing Countries

Add yours

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Powered by WordPress.com.

Up ↑

%d bloggers like this: